Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

US pricing plan slammed for imposing “foreign price controls”

US pricing plan slammed for imposing “foreign price controls”

US pricing plan slammed for imposing “ foreign price controls”. Trump returns to popular theme ahead of mid-term elections. ... The aim is to stop high prices in the US subsidising the pharma industry as it negotiates lower prices with other

Latest news

  • Merck & Co picks Nike exec to be digital transformation leader Merck & Co picks Nike exec to be digital transformation leader

    Merck &Co has appointed Nike’s Jim Scholefield to be its new chief information and digital officer, continuing a trend in pharma to hire in expertise from the consumer world. ... Scholefield starts work at the US pharma giant on 29 October and will be

  • US says medicine ads should include list prices US says medicine ads should include list prices

    US says medicine ads should include list prices. Hopes the proposal will encourage lower prescription drug prices. ... The US government has said pharma companies should disclose the list price of products in direct-to-consumer TV advertising, as part of

  • Teva wins FDA OK for crucial migraine drug Teva wins FDA OK for crucial migraine drug

    Teva has secured US approval for migraine drug Ajovy, a key part of new chief execeutive Kåre Schultz's turnaround plan for the company. ... On balance, GlobalData is putting Aimovig out in front in 2026 given its first-mover advantage generating nearly

  • Pfizer abandons antibody for Duchenne Pfizer abandons antibody for Duchenne

    The big pharma company halted two trials of the anti-myostatin antibody, which is designed to build muscle mass and strength. ... At the moment these are the only two drugs available to treat the underlying dystrophin gene mutation in some DMD patients,

  • Pfizer signs $425m flu vaccine deal with Germany’s BioNTech Pfizer signs $425m flu vaccine deal with Germany’s BioNTech

    Pfizer signs $425m flu vaccine deal with Germany’ s BioNTech. Pharma giant will take on development and commercial responsibility for candidates. ... The US pharma giant has just signed a front-loaded deal with BioNTech – with $120m in upfront and

More from news
Approximately 8 fully matching, plus 490 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... AstraZeneca is just one of several multinational pharma companies working with China’s homegrown tech companies.

  • Made in China Made in China

    to encourage a home-grown pharma industry, as well as investment from multinational giant. ... Big pharma reaps the benefits. There is no question that established US and European big pharma companies are also reaping the benefits of the new China boom.

  • A new era of smart pharma A new era of smart pharma

    A new era of smart pharma. How smarter pharmaceuticals and pharmacovigilance are transforming healthcare. ... Pharma companies are having to adapt and innovate to keep pace with the vast changes brought about by digital technology.

  • Six degrees of participation Six degrees of participation

    The era of Participatory Medicine - aka collaborative care or shared decision-making - is upon us, and fittingly for pharma, it’s the taking part that counts. ... UK, as well as the Head of Digital and therapeutic heads from within the pharma client

More from intelligence
Approximately 0 fully matching, plus 44 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 40 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics